Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P de Cremoux

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenograftsF Nemati, A Livartowski, P De Cremoux, et al.
Biochemical Pharmacology|September 15, 1989
1,25 Dihydroxyvitamin D3 modulates adenylate cyclase activity of the human breast cancer cell line T47D through increased synthesis of GsP de Cremoux, F Calvo, G Lagier, et al.
European Journal of Haematology|September 1, 1996
Decreased IL-1 beta and TNF alpha secretion in long-term bone marrow culture supernatant from Fanconi's anaemia patientsP de Cremoux, E Gluckman, M P Podgorniak, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
1,25-Dihydroxycholecalciferol induces an increase in PGE1- and forskolin-stimulated cyclic-AMP production in T47D human breast cancer cell lineP de Cremoux, F Calvo, H Cost, et al.
The International Journal of Biological Markers|April 14, 2000
Illegitimate villin transcripts in normal bone marrow precludes detection of colon cancer micrometastasesC Salbe, P de Cremoux, C Bonneton, et al.
International Journal of Cancer|October 9, 1996
Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6A Degeorges, R Tatoud, F Fauvel-Lafeve, et al.
The Histochemical Journal|January 1, 1995
Combined analysis of in situ hybridization, cell cycle and structural markers using reflectance and immunofluorescence confocal microscopyG Linares-Cruz, G Millot, P De Cremoux, et al.
International Journal of Immunopharmacology|January 1, 1987
Quantitative modifications of major histocompatibility complex (MHC) antigens induced by recombinant gamma interferon in two human breast cancer linesF Calvo, N Jabrane, A Faille, et al.
Endocrine-Related Cancer|September 25, 2003
Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogensP de Cremoux, C Tran-Perennou, B L Brockdorff, et al.
Breast Cancer Research and Treatment|March 11, 1998
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?A Degeorges, A de Roquancourt, J M Extra, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenograftsF Nemati, A Livartowski, P De Cremoux, et al.
Biochemical Pharmacology|September 15, 1989
1,25 Dihydroxyvitamin D3 modulates adenylate cyclase activity of the human breast cancer cell line T47D through increased synthesis of GsP de Cremoux, F Calvo, G Lagier, et al.
European Journal of Haematology|September 1, 1996
Decreased IL-1 beta and TNF alpha secretion in long-term bone marrow culture supernatant from Fanconi's anaemia patientsP de Cremoux, E Gluckman, M P Podgorniak, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
1,25-Dihydroxycholecalciferol induces an increase in PGE1- and forskolin-stimulated cyclic-AMP production in T47D human breast cancer cell lineP de Cremoux, F Calvo, H Cost, et al.
The International Journal of Biological Markers|April 14, 2000
Illegitimate villin transcripts in normal bone marrow precludes detection of colon cancer micrometastasesC Salbe, P de Cremoux, C Bonneton, et al.
International Journal of Cancer|October 9, 1996
Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6A Degeorges, R Tatoud, F Fauvel-Lafeve, et al.
The Histochemical Journal|January 1, 1995
Combined analysis of in situ hybridization, cell cycle and structural markers using reflectance and immunofluorescence confocal microscopyG Linares-Cruz, G Millot, P De Cremoux, et al.
International Journal of Immunopharmacology|January 1, 1987
Quantitative modifications of major histocompatibility complex (MHC) antigens induced by recombinant gamma interferon in two human breast cancer linesF Calvo, N Jabrane, A Faille, et al.
Endocrine-Related Cancer|September 25, 2003
Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogensP de Cremoux, C Tran-Perennou, B L Brockdorff, et al.
Breast Cancer Research and Treatment|March 11, 1998
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?A Degeorges, A de Roquancourt, J M Extra, et al.
Pageof 6